Hybrid pharmacological and ablative therapy for the management of symptomatic atrial fibrillation

BACKGROUND: Hybrid therapy for atrial fibrillation class 1C and class III antiarrhythmic drugs (AAD) can convert atrial fibrillation (AF) into an isthmus-dependent atrial flutter (AFL) in more than 10% of patients. Hybrid pharmacological and ablative therapy offers a safe and effective approach to a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kimman, G.P., Szili-Torok, T., Nieuwdorp, M., Theuns, D.A.M.J., Scholten, M., Jordaens, L.
Format: Artigo
Idioma:Inglês
Publicat: 2002
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2499668/
https://ncbi.nlm.nih.gov/pubmed/25696026
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars